Walgreens Launches 2026–2027 Flu Index as Influenza Activity Rises Four Weeks Earlier Than in Recent Seasons
Walgreens has launched its 2026–2027 Walgreens Flu Index, an interactive online platform designed to help people understand the spread of influenza, COVID-19 and other acute respiratory illnesses across the United States. The tool provides state- and county-level insights into respiratory illness activity, offering communities, healthcare professionals and public health officials information that can support seasonal health planning and preventive measures.
The launch comes as early indicators suggest that influenza activity is increasing sooner than in recent years. According to Walgreens, national flu activity is tracking approximately four weeks ahead of recent flu seasons, with increases reported across several western states and Florida. The company has also observed an increase in flu antiviral prescriptions compared with the same period last year, alongside rising consumer demand for cold and flu medications, at-home testing products and other seasonal healthcare supplies.
These early trends highlight the importance of monitoring respiratory illnesses as the 2026–2027 flu season develops. Although activity varies across geographic areas, the early increase provides a reason for individuals to review preventive measures, consider vaccination and prepare for the possibility of respiratory illnesses becoming more widespread in their communities.
The Walgreens Flu Index is updated every Monday and combines several sources of information, including Walgreens flu and COVID-19 testing data, prescription antiviral medications and over-the-counter cold and flu purchasing trends. By bringing these indicators together in one online tool, the company aims to provide a clearer picture of where respiratory illness activity is occurring and how patterns change over time.
Walgreens Flu Index Provides Local and National Respiratory Illness Insights
The 2026–2027 Walgreens Flu Index is designed to make respiratory illness trends easier to understand by presenting information through an interactive map. Users can explore national activity, select individual states and examine county-level information to better understand how flu and other respiratory illnesses are developing in different parts of the country.
The platform monitors influenza, COVID-19 and overall acute respiratory illness activity relative to an annual baseline. Its scoring system ranges from zero, representing the lowest activity, to 10, representing the highest activity. Scores are calculated weekly for each state and territory and more than 1,500 counties.
The index uses multiple indicators rather than relying on a single source of information. Walgreens incorporates data related to flu and COVID-19 testing, antiviral prescriptions and consumer purchasing behavior for common cold and flu products. These sources provide different perspectives on respiratory illness trends, including testing activity, treatment demand and the purchase of products commonly used to manage symptoms.
The combined indicators can help users identify changes in activity and compare current patterns with those observed during previous seasons.
However, the index is not designed to measure the severity of influenza infections or determine how seriously an individual patient may become ill. Instead, its primary purpose is to indicate where respiratory illness activity is occurring and how that activity is changing over time.
This distinction is important because an increase in an activity score does not necessarily mean that infections are more severe. Similarly, consumer purchasing trends and prescription activity are indicators of potential changes in demand, rather than a complete count of all infections in a community.
By presenting these indicators in an accessible format, Walgreens intends to help people understand local trends and make more informed decisions about prevention and preparation.
Early Indicators Point to an Earlier Flu Season
One of the key findings accompanying the launch is that national flu activity is tracking approximately four weeks ahead of recent flu seasons.
Walgreens has identified increases in flu activity across many western states and Florida, suggesting that the seasonal pattern is developing earlier than in recent years. The company has also reported dispensing more flu antiviral prescriptions than during the corresponding period last year.
Antiviral medications are used to treat influenza in appropriate patients and may be particularly important for people at increased risk of complications. Increased dispensing can reflect changes in treatment demand, although prescription trends alone cannot establish the total number of infections in a community.
Consumer purchasing patterns provide another indication of growing concern about respiratory illnesses. Walgreens reports double-digit year-over-year increases in sales of several categories of products associated with cold and flu season.
These include cold and flu medications, at-home COVID-19 and flu tests, cough drops and tea.
The increase in demand suggests that consumers may be preparing for seasonal illnesses or responding to symptoms. When considered alongside testing and prescription data, these purchasing patterns contribute to the broader picture presented by the Walgreens Flu Index.
Nevertheless, respiratory virus activity can differ considerably from one community to another. An increase in one state does not necessarily indicate that the same trend is occurring nationwide at the same rate.
For this reason, access to local information may be especially useful during the early weeks of the flu season. The Walgreens Flu Index allows users to examine their geographic area instead of relying exclusively on national summaries.
As activity develops, weekly updates can help users follow changes and compare current trends with those observed during the previous season.
Vaccination Remains an Important Preventive Measure
With influenza activity increasing earlier than in recent years, Walgreens is encouraging eligible individuals to consider getting vaccinated before the virus becomes more widespread in their communities.
Influenza vaccines are updated annually to help protect against the strains expected to circulate during the upcoming season. Vaccination remains an important public health measure because influenza can cause illness ranging from relatively mild symptoms to serious complications requiring hospitalization.
The risk of severe illness can be greater for certain groups, including older adults, young children and people with underlying health conditions. Vaccination decisions should take individual circumstances and current public health recommendations into account.
Rick Gates, Walgreens’ chief pharmacy and enterprise external affairs officer, emphasized the value of local information in helping people make preventive health decisions.
“Flu activity can vary significantly from one community to another, and knowing what’s happening locally can make a real difference,” Gates said. “The Walgreens Flu Index gives people timely information to make informed decisions about prevention, including getting vaccinated before flu becomes more widespread in their community.”
The company’s message emphasizes that individuals do not need to wait until flu activity reaches a high level in their neighborhood before considering vaccination.
Because respiratory illness patterns can change throughout the season, taking preventive measures early may help individuals prepare for later increases in local transmission.
Walgreens also advises people to consult pharmacists and healthcare professionals when they have questions about vaccination eligibility, available vaccine options or other preventive measures.
Multiple Flu Vaccine Options Available at Walgreens
Walgreens offers several influenza vaccine options through its pharmacy network. According to the company, these include standard-dose vaccines, higher-dose vaccines recommended by the U.S. Centers for Disease Control and Prevention (CDC) for adults aged 65 and older, and an mRNA flu vaccine at select locations.
Vaccine availability may vary by location, and patients should confirm which options are offered at their local pharmacy.
The company is promoting both walk-in vaccination and advance appointment scheduling to make the process more convenient for patients.
Individuals can schedule vaccinations for up to four patients through the Walgreens website at Walgreens.com/ScheduleVaccine. Appointments can also be arranged through the Walgreens mobile application, by texting “Flu” to 66879 or by calling 1-800-WALGREENS.
Walk-ins are welcome at local Walgreens pharmacies, subject to vaccine availability and applicable requirements.
To accommodate seasonal demand, Walgreens says it is increasing pharmacy staffing, expanding appointment availability and allowing patients to schedule vaccinations further in advance.
These measures are intended to help patients access vaccination services while reducing some of the logistical challenges associated with arranging preventive care during busy respiratory illness seasons.
The availability of different scheduling options may be particularly useful for families and individuals seeking to coordinate appointments for multiple eligible household members.
Walgreens Introduces Rewards to Encourage Preventive Care
Alongside its vaccination services, Walgreens is offering eligible myWalgreens members financial incentives connected to vaccination and subsequent purchases.
According to the company’s announcement, patients who receive a vaccine at Walgreens can earn $15 in Walgreens Cash rewards on their next eligible in-store purchase of $5 or more as a myWalgreens member.
Eligible myWalgreens members can also receive 10% back in Walgreens Cash rewards on eligible purchases for the following 30 days.
The offers are subject to the program’s applicable terms and conditions.
These incentives form part of Walgreens’ broader effort to encourage participation in preventive healthcare while connecting pharmacy services with the company’s retail health offerings.
Pharmacies can play an important role in preventive care by providing convenient access to vaccinations, helping patients understand available services and offering guidance on common health concerns.
By combining vaccination access, digital information and rewards, Walgreens is seeking to make seasonal health preparation more accessible to consumers.
However, individuals should review the applicable terms and eligibility requirements before relying on rewards when planning their purchases.
Pharmacists Support Patients Managing Cold and Flu Symptoms
Vaccination is one component of seasonal respiratory illness preparation. Walgreens is also encouraging customers to keep commonly used cold and flu supplies available at home and seek appropriate guidance when symptoms develop.
Pharmacists can help patients understand over-the-counter products, review product instructions and identify circumstances in which consultation with a healthcare professional may be appropriate.
Walgreens highlights several products that consumers may consider keeping on hand during respiratory illness season.
These include its Maximum Strength Daytime and Nighttime Severe Cold and Flu Caplets, Honey Lemon Cough Drops, Sugar Free Hydration Plus Electrolyte Drink Mix and Vitamin C supplements.
Different products serve different purposes. Cold and flu medications may help relieve certain symptoms, while cough drops can provide temporary relief for throat irritation. Hydration products may help individuals maintain fluid intake when they are unwell, although their suitability depends on individual needs.
Vitamin supplements should not be considered a substitute for vaccination or medical treatment when needed.
Consumers should follow product labeling and seek advice from a pharmacist or healthcare professional if they are unsure which products are appropriate. This is especially important for people who take multiple medications, have underlying health conditions or are purchasing products for children.
Some cold and flu products contain overlapping active ingredients, so combining medications without checking their contents can lead to accidental duplication.
People who experience severe symptoms, difficulty breathing, dehydration or other concerning changes should seek appropriate medical care rather than relying solely on over-the-counter products.
By combining access to seasonal supplies with pharmacist guidance, Walgreens aims to support customers as they navigate common respiratory illnesses throughout the season.
Why Walgreens Created the Flu Index
Walgreens says the Flu Index extends its longstanding role in communities across the United States. The company has operated for 125 years and has developed a broad pharmacy network through which it provides healthcare products, pharmacy services and information to consumers.
Its nationwide presence gives the company visibility into several aspects of seasonal respiratory illness activity, including testing, prescription treatment and purchases of products used to manage symptoms.
Walgreens created the index to bring these observations together in a format that people can use to understand changing local conditions.
The tool is intended for a broad audience that includes community members, media organizations, healthcare providers and public health officials. Each group may use the information differently, but all can benefit from a clearer understanding of geographic and seasonal trends.
For individuals, the index can provide additional context when deciding whether to review vaccination options or prepare household supplies.
For healthcare professionals and public health observers, it can offer another source of information about changing activity and consumer demand.
The index should not be treated as a replacement for official public health surveillance, laboratory-confirmed case counts or professional medical advice. Instead, it offers an additional perspective based on the indicators Walgreens collects.
Its weekly updates are intended to make it easier to follow changes throughout the respiratory illness season.
Frequently Asked Questions About the Walgreens Flu Index
What does the Walgreens Flu Index measure?
The index tracks influenza, COVID-19 and overall acute respiratory illness activity across the United States. It combines Walgreens testing data, prescription antiviral activity and over-the-counter cold and flu purchasing trends to calculate weekly scores for states, territories and more than 1,500 counties.
How often is the index updated?
Walgreens updates the index every Monday, allowing users to follow changes in activity over time and compare current patterns with those of the previous season.
Does a high score mean the flu is more severe?
No. The index measures relative activity, not the severity of infections or the likelihood that an individual will develop serious complications. It is intended to help users understand where respiratory illnesses are occurring and how activity is changing.
Should people get vaccinated if flu activity is low locally?
Eligible individuals should consider vaccination in accordance with current public health recommendations, even if activity in their area is currently low. Local conditions can change as the season progresses, and vaccination timing can be discussed with a pharmacist or healthcare professional.
How can patients receive a flu vaccine at Walgreens?
Patients can visit participating Walgreens pharmacies for walk-in vaccination or schedule appointments through the company’s website, mobile application, text service or telephone line. Vaccine options and availability may vary by location.
Digital Monitoring and Prevention Take Center Stage
The launch of the 2026–2027 Walgreens Flu Index highlights the growing role of digital tools in communicating seasonal respiratory illness trends. By combining testing information, prescription activity and consumer purchasing patterns, Walgreens is providing a resource designed to help communities understand where influenza and other respiratory illnesses are increasing.
The company’s early indicators suggest that flu activity is developing approximately four weeks ahead of recent seasons, with increases in several western states and Florida, alongside higher demand for antiviral prescriptions and cold and flu products.
Although the index does not measure disease severity or replace official public health surveillance, its geographic insights may help users follow changing conditions and prepare for the months ahead.
Walgreens is pairing the index with expanded vaccination access, multiple vaccine options, pharmacy staffing initiatives and pharmacist support for symptom management. Together, these measures reflect the company’s approach to seasonal health preparation, combining digital information with accessible pharmacy services.
As the 2026–2027 respiratory illness season progresses, vaccination, appropriate hygiene practices, informed use of medications and timely medical advice remain important components of prevention and care. The Walgreens Flu Index offers an additional way for individuals and communities to stay informed as local respiratory illness patterns evolve.
Source link: https://corporate.walgreens.com/
